Kaoru Funabashi
Impact in
-
- Nitric Oxide and Endothelin Effects
Papers in
-
- Fibroblast Growth Factor Research 2
- PI3K/AKT/mTOR signaling in cancer 2
- Receptor Mechanisms and Signaling 2
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Toshihiko Saeki (2 shared papers)Takahiro Fukuroda (2 shared papers)Takehiro Fukami (1 shared paper)Masaki Ihara (1 shared paper)Kiyofumi Ishikawa (1 shared paper)Hiroyuki Suda (1 shared paper)Mitsuo Yano (1 shared paper)Hirokazu Ohsawa (3 shared papers)
- Journals
- Journal of Cardiovascular Pharmacology (2 papers)Cancer Research (2 papers)Molecular Cancer Research (1 paper)ACS Medicinal Chemistry Letters (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Kaoru Funabashi
11 papers receiving 464 citations
Peers
Comparison fields: 5 of 68
- Physiology 132
- Oncology 125
- Molecular Biology 283
- Pulmonary and Respiratory Medicine 110
- Biophysics 17
Countries citing papers authored by Kaoru Funabashi
This map shows the geographic impact of Kaoru Funabashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Funabashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Funabashi more than expected).
Fields of papers citing papers by Kaoru Funabashi
This network shows the impact of papers produced by Kaoru Funabashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Funabashi. The network helps show where Kaoru Funabashi may publish in the future.
Co-authors
The 25 scholars most cited alongside Kaoru Funabashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 137 | |
| 2 | 1992 | 102 | |
| 3 | 2019 | 55 | |
| 4 | 2018 | 48 | |
| 5 | 2009 | 46 | |
| 6 | 1991 | 45 | |
| 7 | 2023 | 16 | |
| 8 | 2019 | 12 | |
| 9 | 2022 | 8 | |
| 10 | 1996 | 5 | |
| 11 | 2018 | 1 |
About Kaoru Funabashi
Kaoru Funabashi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Physiology and Rheumatology, having authored 11 papers that have together received 475 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), HER2/EGFR in Cancer Research (3 papers), Fibroblast Growth Factor Research (2 papers), Nitric Oxide and Endothelin Effects (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Receptor Mechanisms and Signaling (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Physiology (132 citations), Oncology (125 citations), Molecular Biology (283 citations), Pulmonary and Respiratory Medicine (110 citations) and Biophysics (17 citations). Kaoru Funabashi has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Toshihiko Saeki, Takahiro Fukuroda, Takehiro Fukami, Masaki Ihara, Kiyofumi Ishikawa, Hiroyuki Suda, Mitsuo Yano, Hirokazu Ohsawa, Kenichi Matsuo and Takeshi Sagara. Their work appears in journals such as Journal of Cardiovascular Pharmacology, Cancer Research, Molecular Cancer Research, ACS Medicinal Chemistry Letters and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.